Proto Script Pharmaceutical Corp
Proto Script Pharmaceutical Corp. engages in the repair and rental of power wheelchairs and scooters. The company serves federal, state, and private insurance providers. Proto Script Pharmaceutical Corp. was founded in 2001 and is headquartered in Rancho Cucamonga, California.
Proto Script Pharmaceutical Corp (PSCR) - Total Assets
Latest total assets as of September 2017: $234.56K USD
Based on the latest financial reports, Proto Script Pharmaceutical Corp (PSCR) holds total assets worth $234.56K USD as of September 2017.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Proto Script Pharmaceutical Corp - Total Assets Trend (2010–2016)
This chart illustrates how Proto Script Pharmaceutical Corp’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Proto Script Pharmaceutical Corp - Asset Composition Analysis
Current Asset Composition (December 2016)
Proto Script Pharmaceutical Corp's total assets of $234.56K consist of 85.0% current assets and 15.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 2.1% |
| Accounts Receivable | $140.00K | 82.3% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $25.55K | 15.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2010–2016)
This chart illustrates how Proto Script Pharmaceutical Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Proto Script Pharmaceutical Corp's current assets represent 85.0% of total assets in 2016, a decrease from 100.0% in 2010.
- Cash Position: Cash and equivalents constituted 2.1% of total assets in 2016, down from 63.5% in 2010.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2010.
- Asset Diversification: The largest asset category is accounts receivable at 82.3% of total assets.
Proto Script Pharmaceutical Corp Competitors by Total Assets
Key competitors of Proto Script Pharmaceutical Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shaanxi Jinye Science Technology and Education Group Co Ltd
SHE:000812
|
China | CN¥5.75 Billion |
|
Tungkong Inc
SHE:002117
|
China | CN¥1.92 Billion |
|
Eternal Asia Supply Chain Management Ltd
SHE:002183
|
China | CN¥54.04 Billion |
|
Hongbo Co Ltd
SHE:002229
|
China | CN¥2.43 Billion |
|
Beijing Shengtong Printing Co Ltd
SHE:002599
|
China | CN¥2.14 Billion |
|
Shanghai Nar Industrial Co Ltd
SHE:002825
|
China | CN¥2.78 Billion |
|
Xuchang Ketop Testing Research Ins
SHE:003008
|
China | CN¥1.10 Billion |
|
GFM Services Bhd
KLSE:0039
|
Malaysia | RM644.83 Million |
Proto Script Pharmaceutical Corp - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Proto Script Pharmaceutical Corp generates 4.64x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Proto Script Pharmaceutical Corp is currently not profitable relative to its asset base.
Proto Script Pharmaceutical Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.11 | 0.87 | 6.91 |
| Quick Ratio | 0.11 | 0.87 | 6.91 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-1.49 Million | $ -36.99K | $ 51.83K |
Proto Script Pharmaceutical Corp - Advanced Valuation Insights
This section examines the relationship between Proto Script Pharmaceutical Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.03 |
| Asset Growth Rate (YoY) | 1348.4% |
| Total Assets | $170.19K |
| Market Capitalization | $4.91K USD |
Valuation Analysis
Below Book Valuation: The market values Proto Script Pharmaceutical Corp's assets below their book value (0.03 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Proto Script Pharmaceutical Corp's assets grew by 1348.4% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Proto Script Pharmaceutical Corp (2010–2016)
The table below shows the annual total assets of Proto Script Pharmaceutical Corp from 2010 to 2016.
| Year | Total Assets | Change |
|---|---|---|
| 2016-12-31 | $170.19K | +1348.43% |
| 2016-06-30 | $11.75K | 0.00% |
| 2016-05-31 | $11.75K | -94.09% |
| 2015-12-31 | $198.94K | -56.15% |
| 2014-12-31 | $453.71K | +145788.42% |
| 2013-12-31 | $311.00 | -99.14% |
| 2012-12-31 | $36.02K | -40.56% |
| 2011-12-31 | $60.60K | +197.40% |
| 2010-12-31 | $20.38K | -- |